T-HEMOVINE 作为局部止血剂的功效：临床研究

Open Access Macedonian Journal of Medical Sciences Pub Date : 2023-07-14 DOI:10.3889/oamjms.2023.11224

Andi Asadul Islam, Juliani Ibrahim, Venansius R. Kurniawan

{"title":"T-HEMOVINE 作为局部止血剂的功效：临床研究","authors":"Andi Asadul Islam, Juliani Ibrahim, Venansius R. Kurniawan","doi":"10.3889/oamjms.2023.11224","DOIUrl":null,"url":null,"abstract":"AIM: Clinical trials using hemostatic T-Hemovine derived from bovine gelatin, to stop bleeding during surgery was performed. METHODS: Twenty (20) patients (aged 8 months–70 years) who underwent neurosurgery at Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Teaching Hospital, from September 16, to December 13, 2019, are willing to receive T-Hemovine to control bleeding. RESULTS: This approach was successfully used in twenty patients. Four patients stopped bleeding at the 3rd min (20%), nineteen patients stopped bleeding at the 5th min or less (95%) and twenty patients stopped bleeding before the 10th min (100%). There were no post-operative bleeding events, no infection, and no other post-operative complications. CONCLUSION: Therefore, there is no effect, and the safety of using T-Hemovine hemostatic is the same as the effect and safety of using surgeon hemostatic and other hemostatic.","PeriodicalId":19562,"journal":{"name":"Open Access Macedonian Journal of Medical Sciences","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of T-HEMOVINE as Topical Hemostatic Agent: A Clinical Study\",\"authors\":\"Andi Asadul Islam, Juliani Ibrahim, Venansius R. Kurniawan\",\"doi\":\"10.3889/oamjms.2023.11224\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AIM: Clinical trials using hemostatic T-Hemovine derived from bovine gelatin, to stop bleeding during surgery was performed. METHODS: Twenty (20) patients (aged 8 months–70 years) who underwent neurosurgery at Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Teaching Hospital, from September 16, to December 13, 2019, are willing to receive T-Hemovine to control bleeding. RESULTS: This approach was successfully used in twenty patients. Four patients stopped bleeding at the 3rd min (20%), nineteen patients stopped bleeding at the 5th min or less (95%) and twenty patients stopped bleeding before the 10th min (100%). There were no post-operative bleeding events, no infection, and no other post-operative complications. CONCLUSION: Therefore, there is no effect, and the safety of using T-Hemovine hemostatic is the same as the effect and safety of using surgeon hemostatic and other hemostatic.\",\"PeriodicalId\":19562,\"journal\":{\"name\":\"Open Access Macedonian Journal of Medical Sciences\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Access Macedonian Journal of Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3889/oamjms.2023.11224\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Macedonian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3889/oamjms.2023.11224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的：使用从牛明胶中提取的止血剂 T-Hemovine 在手术中止血的临床试验。方法：2019年9月16日至12月13日期间，在瓦希丁-苏迪罗胡索多博士医院和哈桑努丁大学教学医院接受神经外科手术的20名患者（8个月至70岁）愿意接受T-Hemovine止血。结果：20 名患者成功使用了这种方法。4名患者在第3分钟止血（20%），19名患者在第5分钟或更短时间内止血（95%），20名患者在第10分钟前止血（100%）。术后无出血事件，无感染，无其他术后并发症。结论：因此，使用 T-埃莫维止血剂与使用外科医生止血剂和其他止血剂的效果和安全性相同，没有任何影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Efficacy of T-HEMOVINE as Topical Hemostatic Agent: A Clinical Study

AIM: Clinical trials using hemostatic T-Hemovine derived from bovine gelatin, to stop bleeding during surgery was performed. METHODS: Twenty (20) patients (aged 8 months–70 years) who underwent neurosurgery at Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Teaching Hospital, from September 16, to December 13, 2019, are willing to receive T-Hemovine to control bleeding. RESULTS: This approach was successfully used in twenty patients. Four patients stopped bleeding at the 3rd min (20%), nineteen patients stopped bleeding at the 5th min or less (95%) and twenty patients stopped bleeding before the 10th min (100%). There were no post-operative bleeding events, no infection, and no other post-operative complications. CONCLUSION: Therefore, there is no effect, and the safety of using T-Hemovine hemostatic is the same as the effect and safety of using surgeon hemostatic and other hemostatic.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Open Access Macedonian Journal of Medical Sciences Medicine-Medicine (all)

自引率

0.00%

发文量

1225

期刊介绍： Open Access Macedonian Journal of Medical Sciences (OAMJMS) [formerly known as Macedonian Journal of Medical Sciences] is a top-tier open access medical science journal published by the ID Design 2012/DOOEL Skopje, Rajko Zhinzifov No 48, 1000 Skopje, Republic of Macedonia. OAMJMS is an international, modern, general medical journal covering all areas in the medical sciences, from basic studies to large clinical trials and cost-effectiveness analyses. We publish mostly human studies that substantially enhance our understanding of disease epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; trials that test the efficacy of specific interventions and those that compare different treatments; and systematic reviews. We aim to promote translation of basic research into clinical investigation, and of clinical evidence into practice. We publish occasional studies in animal models when they report outstanding research findings that are highly clinically relevant. Our audience is the international medical community as well as educators, policy makers, patient advocacy groups, and interested members of the public around the world. OAMJMS is published quarterly online version. The Open Access Macedonian Journal of Medical Sciences (OAMJMS) publishes Medical Informatics, Basic Science, Clinical Science, Case Report, Brief Communication, Public Health, Public Policy, and Review Article from all fields of medicine and related fields. This journal also publishes, continuously or occasionally, the bibliographies of the members of the Society, medical history, medical publications, thesis abstracts, book reviews, reports on meetings, information on future meetings, important events and dates, and various headings which contribute to the development of the corresponding scientific field.